相关实验视频
Updated: Sep 13, 2025

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
雌激素受体α调节人类乳腺癌细胞中的SVCT2蛋白水平
Soon Young Jang1,2, Eunbi Hong1, Yebin Jo1
1Department of Applied Chemistry, Dongduk Women's University, 60 Hwarang-Ro 13-Gil, Seongbuk-Gu, Seoul, Korea.
雌激素受体α (ERα) 通过XIAP调节甲酸盐运输体SVCT2的稳定性,影响乳腺癌的化学抵抗. 调节XIAP或SVCT2可以克服ERα阳性乳腺癌的耐药性.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 营养物质的运输机制.
背景情况:
- 溶解物载体 (SLC) 蛋白质运输分子并参与信号传递.
- 甲酸转运体SVCT2在ERα阳性乳腺癌中的作用尚不清楚.
- 雌激素受体α (ERα) 是乳腺癌的关键调节者.
研究的目的:
- 研究SVCT2.2的ERα调节.
- 阐明SVCT2在化学抵抗中的作用.
- 确定ERα阳性乳腺癌的治疗点.
主要方法:
- 分析ERα淘汰和SVCT2蛋白水平.
- 对ERα-SVCT2相互作用的研究.
- 通过XIAP介导的全方位化和蛋白质体降解试验.
- 对多克索鲁比细胞毒性和ABC载体基因表达的评估.
主要成果:
- 降低了SVCT2水平和甲酸吸收.
- ERα与SVCT2直接相互作用.
- XIAP针对SVCT2在ERα缺乏细胞中的降解.
- 通过XIAP静音,恢复了SVCT2的稳定性.
- 抑制ERα或SVCT2降低了多克索鲁比辛的敏感性和增加了ABC载体表达.
结论:
- 发现了一个由XIAP介导的新型ERα-SVCT2调节轴.
- SVCT2对于酸水平和药物敏感性至关重要.
- 准XIAP或SVCT2为ERα阳性乳腺癌中化学抵抗提供了潜在的治疗策略.
更多相关视频
10:36Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
相关概念视频
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Nuclear Protein Sorting
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Regulation of Angiogenesis and Blood Supply